Metropolitan Life Insurance Company (MetLife)’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-58,717
Closed -$10.1M 2749
2015
Q1
$10.1M Buy
58,717
+1,945
+3% +$286K 0.07% 266
2014
Q4
$6.53M Buy
56,772
+619
+1% +$75K 0.05% 412
2014
Q3
$8.77M Buy
56,153
+553
+1% +$80.2K 0.06% 299
2014
Q2
$6.86M Buy
55,600
+322
+0.6% +$35.6K 0.05% 396
2014
Q1
$5.73M Buy
55,278
+1,348
+2% +$138K 0.04% 467
2013
Q4
$4.85M Buy
53,930
+1,173
+2% +$93.6K 0.03% 527
2013
Q3
$3.53M Buy
52,757
+48,483
+1,134% +$3.34M 0.03% 645
2013
Q2
$283K Buy
+4,274
New +$244K ﹤0.01% 2094

Other funds holding SLXP

Metropolitan Life Insurance Company (MetLife)'s SLXP Position: Q2 2015 in Review

Metropolitan Life Insurance Company (MetLife) sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 58,717 shares — an estimated $10.1M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $10.1M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 58,717 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $10.1M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s SALIX PHARMACEUTICALS LTD DEL position peaked at $10.1M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2015, filed 17 Aug 2015.